News | January 07, 2008

Young, Obese Women with PCOS at Risk for Coronary Atherosclerosis

January 8, 2008 – Young, obese women with polycystic ovary syndrome (PCOS) may be at increased risk for early subclinical coronary atherosclerosis, independent of the presence of traditional cardiovascular risk factors and novel inflammatory risk markers, according to a study by researchers at the University of Iowa published in the December issue of the Journal of Clinical Endocrinology and Metabolism.

The study involved 24 women, between 21 and 50 years of age, with PCOS and a body mass index of 30 or higher, and 24 weight- and age-matched controls without PCOS. Eight of 24 PCOS subjects, or 33 percent, and two of 24 controls, or 8 percent, were diagnosed with coronary artery calcium, an indicator of early-onset atherosclerosis.

Additionally, researchers found that the majority of women with detectable coronary artery calcium did not have traditional cardiovascular risk factors “and the presence of PCOS status per se appeared to contribute to this increased risk of coronary artery calcium,” said Rupal Shroff, M.D., one of the researchers at University of Iowa.

For more information:

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Overlay Init